OBJECTIVES: To study the practice of continuous deep sedation in 2005 in the Netherlands and compare it with findings from 2001. DESIGN: Questionnaire study about random samples of deaths reported to a central death registry in 2005 and 2001. SETTING: Nationwide physician study in the Netherlands. PARTICIPANTS: Reporting physicians received a questionnaire about the medical decisions that preceded the patient's death; 78% (n=6860) responded in 2005 and 74% (n=5617) in 2001. MAIN OUTCOME MEASURES: Characteristics of continuous deep sedation (attending physician, types of patients, drugs used, duration, estimated effect on shortening life, palliative consultation). Requests for euthanasia. RESULTS: The use of continuous deep sedation increased from 5.6% (95% confidence interval 5.0% to 6.2%) of deaths in 2001 to 7.1% (6.5% to 7.6%) in 2005, mostly in patients treated by general practitioners and in those with cancer (in 2005, 47% of sedated patients had cancer v 33% in 2001). In 83% of cases sedation was induced by benzodiazepines, and in 94% patients were sedated for periods of less than one week until death. Nine per cent of those who received continuous deep sedation had previously requested euthanasia but their requests were not granted. Nine per cent of the physicians had consulted a palliative expert. CONCLUSIONS: The increased use of continuous deep sedation for patients nearing death in the Netherlands and the limited use of palliative consultation suggests that this practice is increasingly considered as part of regular medical practice.
OBJECTIVES: To study the practice of continuous deep sedation in 2005 in the Netherlands and compare it with findings from 2001. DESIGN: Questionnaire study about random samples of deaths reported to a central death registry in 2005 and 2001. SETTING: Nationwide physician study in the Netherlands. PARTICIPANTS: Reporting physicians received a questionnaire about the medical decisions that preceded the patient's death; 78% (n=6860) responded in 2005 and 74% (n=5617) in 2001. MAIN OUTCOME MEASURES: Characteristics of continuous deep sedation (attending physician, types of patients, drugs used, duration, estimated effect on shortening life, palliative consultation). Requests for euthanasia. RESULTS: The use of continuous deep sedation increased from 5.6% (95% confidence interval 5.0% to 6.2%) of deaths in 2001 to 7.1% (6.5% to 7.6%) in 2005, mostly in patients treated by general practitioners and in those with cancer (in 2005, 47% of sedated patients had cancer v 33% in 2001). In 83% of cases sedation was induced by benzodiazepines, and in 94% patients were sedated for periods of less than one week until death. Nine per cent of those who received continuous deep sedation had previously requested euthanasia but their requests were not granted. Nine per cent of the physicians had consulted a palliative expert. CONCLUSIONS: The increased use of continuous deep sedation for patients nearing death in the Netherlands and the limited use of palliative consultation suggests that this practice is increasingly considered as part of regular medical practice.
Authors: Jeroen G J Hasselaar; Rob P B Reuzel; Stans C A H H V M Verhagen; Alexander de Graeff; Kris C P Vissers; Ben J P Crul Journal: Arch Intern Med Date: 2007-06-11
Authors: Judith A C Rietjens; Johannes J M van Delden; Agnes van der Heide; Astrid M Vrakking; Bregje D Onwuteaka-Philipsen; Paul J van der Maas; Gerrit van der Wal Journal: Arch Intern Med Date: 2006-04-10
Authors: Judith A C Rietjens; Agnes van der Heide; Astrid M Vrakking; Bregje D Onwuteaka-Philipsen; Paul J van der Maas; Gerrit van der Wal Journal: Ann Intern Med Date: 2004-08-03 Impact factor: 25.391
Authors: Ian Koper; Agnes van der Heide; Rien Janssens; Siebe Swart; Roberto Perez; Judith Rietjens Journal: Support Care Cancer Date: 2013-09-14 Impact factor: 3.603
Authors: Maud Maessen; Jan H Veldink; Bregje D Onwuteaka-Philipsen; Henk T Hendricks; Helenius J Schelhaas; Hepke F Grupstra; Gerrit van der Wal; Leonard H van den Berg Journal: J Neurol Date: 2014-07-15 Impact factor: 4.849
Authors: Sebastiano Mercadante; Francesco Masedu; Alessandro Mercadante; Franco Marinangeli; Federica Aielli Journal: Support Care Cancer Date: 2017-01-17 Impact factor: 3.603
Authors: S M Bruinsma; J Brown; A van der Heide; L Deliens; L Anquinet; S A Payne; J E Seymour; J A C Rietjens Journal: Support Care Cancer Date: 2014-07-15 Impact factor: 3.603
Authors: Judith A C Rietjens; Paul J van der Maas; Bregje D Onwuteaka-Philipsen; Johannes J M van Delden; Agnes van der Heide Journal: J Bioeth Inq Date: 2009-07-28 Impact factor: 1.352